These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
190 related items for PubMed ID: 22887120
1. HSPB1 is an intracellular antiviral factor against hepatitis B virus. Tong SW, Yang YX, Hu HD, An X, Ye F, Ren H, Li SL, Zhang DZ. J Cell Biochem; 2013 Jan; 114(1):162-73. PubMed ID: 22887120 [Abstract] [Full Text] [Related]
2. Differential regulation of host genes including hepatic fatty acid synthase in HBV-transgenic mice. Zhang H, Li H, Yang Y, Li S, Ren H, Zhang D, Hu H. J Proteome Res; 2013 Jun 07; 12(6):2967-79. PubMed ID: 23675653 [Abstract] [Full Text] [Related]
3. Evaluation of hepatitis B virus replication and proteomic analysis of HepG2.2.15 cell line after cyclosporine A treatment. Xie HY, Xia WL, Zhang CC, Wu LM, Ji HF, Cheng Y, Zheng SS. Acta Pharmacol Sin; 2007 Jul 07; 28(7):975-84. PubMed ID: 17588333 [Abstract] [Full Text] [Related]
4. Protein profile in hepatitis B virus replicating rat primary hepatocytes and HepG2 cells by iTRAQ-coupled 2-D LC-MS/MS analysis: Insights on liver angiogenesis. Zhang J, Niu D, Sui J, Ching CB, Chen WN. Proteomics; 2009 May 07; 9(10):2836-45. PubMed ID: 19405029 [Abstract] [Full Text] [Related]
5. Protein alteration of HepG2.2.15 cells induced by iron overload. Fang C, Zhao C, Liu X, Yang P, Lu H. Proteomics; 2012 May 07; 12(9):1378-90. PubMed ID: 22589187 [Abstract] [Full Text] [Related]
6. [Roles of full-length and truncated hepatitis B virus X protein and of interactions with the host-encoded damaged DNA binding protein 1 in HBV replication]. Yang X, He S, Luo N, Luo L, Fan H, Gong Q. Zhonghua Gan Zang Bing Za Zhi; 2013 Jun 07; 21(6):446-51. PubMed ID: 24034847 [Abstract] [Full Text] [Related]
7. Control of HBV replication by antiviral microRNAs transferred by lentiviral vectors for potential cell and gene therapy approaches. Kumar M, Follenzi A, Garforth S, Gupta S. Antivir Ther; 2012 Jun 07; 17(3):519-28. PubMed ID: 22300804 [Abstract] [Full Text] [Related]
8. Whole genome expression profiling of hepatitis B virus-transfected cell line reveals the potential targets of anti-HBV drugs. Ding XR, Yang J, Sun DC, Lou SK, Wang SQ. Pharmacogenomics J; 2008 Feb 07; 8(1):61-70. PubMed ID: 17505500 [Abstract] [Full Text] [Related]
9. Suppression of hepatitis B virus replication by microRNA-199a-3p and microRNA-210. Zhang GL, Li YX, Zheng SQ, Liu M, Li X, Tang H. Antiviral Res; 2010 Nov 07; 88(2):169-75. PubMed ID: 20728471 [Abstract] [Full Text] [Related]
10. [Comparisons of the characteristics and mechanisms of HBV replication in QSG-7701 and HepG2 cell lines]. Pan XB, Zhu L, Gao Y, Chen HS, Wei L. Zhonghua Gan Zang Bing Za Zhi; 2007 Feb 07; 15(2):83-7. PubMed ID: 17362629 [Abstract] [Full Text] [Related]
11. Proteomic analysis of the interleukin-4 (IL-4) response in hepatitis B virus-positive human hepatocelluar carcinoma cell line HepG2.2.15. Yao Y, Li J, Lu Z, Tong A, Wang W, Su X, Zhou Y, Mu B, Zhou S, Li X, Chen L, Gou L, Song H, Yang J, Wei Y. Electrophoresis; 2011 Aug 07; 32(15):2004-12. PubMed ID: 21739463 [Abstract] [Full Text] [Related]
12. Knockdown of HBV surface antigen gene expression by a lentiviral microRNA-based system inhibits HBV replication and HCC growth. Xiangji L, Feng X, Qingbao C, Weifeng T, Xiaoqing J, Baihe Z, Feng S, Hongyang W, Mengchao W. J Viral Hepat; 2011 Sep 07; 18(9):653-60. PubMed ID: 20642484 [Abstract] [Full Text] [Related]
13. RNA interference inhibits hepatitis B virus gene expression and replication in HepG2-N10 cells. Ren JL, Pan JS, Cheng T, Dong J, Lu YP, Huang SJ, Shi HX, Wang L, Lian YM. Chin J Dig Dis; 2006 Sep 07; 7(4):230-6. PubMed ID: 17054586 [Abstract] [Full Text] [Related]
14. [Role of tumor necrosis factor-alpha in the anti-HBV activity of tetracycline]. Ni Y, Jiang F, Xu H, Zeng T, Lei Y, Chen Y, Zhou Z, Ren H. Zhonghua Gan Zang Bing Za Zhi; 2014 Mar 07; 22(3):213-8. PubMed ID: 24824125 [Abstract] [Full Text] [Related]
15. Combination therapy of siRNAs mediates greater suppression on hepatitis B virus cccDNA in HepG2.2.15 cell. Xin XM, Li GQ, Guan XR, Li D, Xu WZ, Jin YY, Gu HX. Hepatogastroenterology; 2008 Mar 07; 55(88):2178-83. PubMed ID: 19260501 [Abstract] [Full Text] [Related]
16. Inhibitory effect of HMGN2 protein on human hepatitis B virus expression and replication in the HepG2.2.15 cell line. Feng Y, He F, Zhang P, Wu Q, Huang N, Tang H, Kong X, Li Y, Lu J, Chen Q, Wang B. Antiviral Res; 2009 Mar 07; 81(3):277-82. PubMed ID: 19150374 [Abstract] [Full Text] [Related]
17. Inhibition of multiple gene expression and virus replication of HBV by stable RNA interference in 2.2.15 cells. Ren X, Luo G, Xie Z, Zhou L, Kong X, Xu A. J Hepatol; 2006 Apr 07; 44(4):663-70. PubMed ID: 16466826 [Abstract] [Full Text] [Related]
18. Proteomics Based Identification of Autotaxin As An Anti-Hepatitis B Virus Factor and a Promoter of Hepatoma Cell Invasion and Migration. She S, Yang M, Hu H, Hu P, Yang Y, Ren H. Cell Physiol Biochem; 2018 Apr 07; 45(2):744-760. PubMed ID: 29414802 [Abstract] [Full Text] [Related]
19. Analysis of gene expression in hepatitis B virus transfected cell line induced by interferon. Xiong W, Wang X, Liu XY, Xiang L, Zheng LJ, Liu JX, Yuan ZH. Sheng Wu Hua Xue Yu Sheng Wu Wu Li Xue Bao (Shanghai); 2003 Dec 07; 35(12):1053-60. PubMed ID: 14673494 [Abstract] [Full Text] [Related]
20. Antisense oligonucleotides targeted against asialoglycoprotein receptor 1 block human hepatitis B virus replication. Yang J, Bo XC, Ding XR, Dai JM, Zhang ML, Wang XH, Wang SQ. J Viral Hepat; 2006 Mar 07; 13(3):158-65. PubMed ID: 16475991 [Abstract] [Full Text] [Related] Page: [Next] [New Search]